Pasithea Therapeutics Corp. (KTTA)
$0.42-6.67%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 0.29
- P/E (TTM)
- -0.17
- Short % float
- 2.18%
- Days to cover
- 1.1
- SI change
- -40.8%
- 1W
- -6.67%
- 1M
- -17.65%
- vs SPY 1W
- -6.53%
- vs SPY 1M
- -20.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on KTTA?
- LOPJLB’s latest quantitative signal on Pasithea Therapeutics Corp. (KTTA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is KTTA in?
- Pasithea Therapeutics Corp. (KTTA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pasithea Therapeutics Corp. (KTTA) do?
- Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacis…